Open an Account
search icon
1
NOTIFICATIONS
Best Algo trading app in India
Bigul

Alembic Pharmaceuticals Ltd - 533573 - Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate

 Pursuant to Regulation 39(3) of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, this is to inform the exchange that the share certificate(s) of the Company has been reported as lost/misplaced and the shareholder(s) or their legal heir(s) of such lost share certificate(s) have requested the Company for issue of duplicate share certificate(s). We enclose herewith a letter received Link Intime India Private Limited, Registrar and Share Transfer Agent giving the proof of the date of receipt of aforesaid information by the Company. We request you to kindly take the same on record.
13-03-2019
Bigul

ALEMBIC PHARMACEUTICALS LTD. - 533573 - Announcement under Regulation 30 (LODR)-Issue of Securities

 With reference to the captioned matter, the exchange is hereby informed that a Meeting of the NCD Committee of the Company will be held on Tuesday, 19th March, 2019, inter-alia to consider and approve the issue and allotment of Unsecured Listed Redeemable Non-Convertible Debentures (NCDs) of upto Rs. 150 Crores on Private Placement Basis under Tranche III, subject to bidding by the eligible investors on the Electronic Book Platform (EBP) provided by National Stock Exchange of India Limited on 18th March, 2019 and acceptance by the Company. We request you to kindly take the same on record.
13-03-2019
Bigul

Alembic Pharmaceuticals Ltd - 533573 - Announcement under Regulation 30 (LODR)-Press Release / Media Release

 With reference to the captioned subject, this is to inform the exchange that the Company's joint venture, Aleor Dermaceuticals Limited, has received US Food and Drug Administration (USFDA) Approval for Clobetasol Propionate Ointment USP, 0.05%. Please find enclosed herewith our press release. We request you to kindly take the same on record.
05-03-2019
Bigul

ALEMBIC PHARMACEUTICALS LTD. - 533573 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation

 Pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we would like to inform that the management of the Company shall be meeting investors/analysts in Hongkong and Singapore during the period from 5th March, 2019 to 8th March, 2019 as part of Non-Deal Roadshow. The meetings will be in group and/or one-on-one format. We request you to kindly take the same on record.
01-03-2019
Bigul

ALEMBIC PHARMACEUTICALS LTD. - 533573 - Loss of Share Certificate / Issue of Duplicate Share Certificate

 Alembic Pharmaceuticals Ltd has informed BSE regarding Loss of Share Certificate / Issue of Duplicate Share Certificate.
21-02-2019
Bigul

Alembic Pharma gets USFDA nod for glaucoma drug

 Drug firm Alembic Pharmaceuticals on Friday said it has received approval from the US health regulator for Acetazolamide extended-release capsules, u
20-02-2019
Bigul

ALEMBIC PHARMACEUTICALS LTD. - 533573 - Announcement under Regulation 30 (LODR)-Press Release / Media Release

 With reference to the captioned subject, this is to inform the exchange that the Company has received US Food & Drug Administration (USFDA) Approval for Acetazolamide Extended-Release Capsules, 500 mg. Please find enclosed herewith our press release. We request you to kindly take the same on record.
20-02-2019
Bigul

Alembic Pharma gets USFDA nod for ophthalmic solution

 New Delhi, Feb 15 (PTI) Drug firm Alembic Pharmaceuticals Friday said it has received approval from the US health regulator for Moxifloxacin Ophthalm
15-02-2019
Bigul

ALEMBIC PHARMACEUTICALS LTD. - 533573 - Announcement under Regulation 30 (LODR)-Press Release / Media Release

 With reference to the captioned subject, this is to inform the exchange that the Company has received US Food & Drug Administration (USFDA) Approval for Moxifloxacin Ophthalmic Solution USP, 0.5%.
15-02-2019
Bigul

ALEMBIC PHARMACEUTICALS LTD. - 533573 - Announcement under Regulation 30 (LODR)-Newspaper Publication

 Pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we enclose herewith a copy of advertisement related to notice of loss of share certificates published by the Company on behalf of the shareholder(s) in English language newspaper - Business Standard on 12th February, 2019. We request you to kindly take the same on record.
12-02-2019
Next Page
Close

Let's Open Free Demat Account